Global Regulators Tighten Oversight Amid Weight Loss Craze and Safety Alarms
Authorities are intensifying scrutiny of pharmaceutical supply chains as weight-loss drug violations rise and new safety data emerges regarding rare-disease therapies.
Authorities are intensifying scrutiny of pharmaceutical supply chains as weight-loss drug violations rise and new safety data emerges regarding rare-disease therapies.
Federal regulators are tightening the definition of 'healthy' beverages while launching a massive enforcement campaign against synthetic kratom concentrates sold in retail outlets.
Scientists at the University of California, Irvine, have identified a signaling molecule called SCUBE3 that potently stimulates hair growth. The discovery stems from studying hairy skin moles and could lead…
Conservative states are opting for stricter eligibility checks and shorter exemption windows for Medicaid enrollees despite a federal offer to delay rigorous documentation requirements until 2028.
Recent fires in new medical facilities and prolonged nursing strikes highlight the fragility of healthcare systems struggling with safety oversight and fiscal instability.
Rising demand for weight-loss medications is straining private employer health plans and triggering new federal pilot programs to manage high costs.
The Trump administration implements aggressive import tariffs on major pharmaceutical firms while expanding Medicare price negotiations to forty high-cost drugs, signaling a shift toward domestic manufacturing and federal price controls.
Eli Lilly and Madrigal Pharmaceuticals report significant earnings beats as the healthcare sector grapples with a widening gap between industry titans and struggling small-cap innovators.
HHS Secretary Robert F. Kennedy Jr. and CMS head Dr. Mehmet Oz are withholding $867.5 million from California, citing a crackdown on home-care fraud.